triazoles has been researched along with Koch's Disease in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.70) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 10 (43.48) | 24.3611 |
2020's | 8 (34.78) | 2.80 |
Authors | Studies |
---|---|
Boechat, N; Castelo-Branco, FS; França, RRF; Hoelz, LVB; Menozzi, CAC | 1 |
Chhabhaiya, H; Dadlani, VG; Somani, RR; Tripathi, PK | 1 |
Albelwi, FF; Aouad, MR; El Ashry, ESH; El Kilany, Y; El Sawy, MA; Elshatanofy, MM; Elwakil, BH; Hagar, M; Jaremko, M; Kandeel, K; Rezki, N | 1 |
Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
Kraft, WK; Lam, E; Schaefer, J; Zhan, T; Zheng, R | 1 |
Deng, J; Tan, Z; Ye, Q; Zhang, Z | 1 |
Grieshober, M; Hauck, S; Mayer, D; Stenger, S; Zenk, SF | 1 |
Ashraf, A; Bhatia, I; Biswal, BK; Dwivedy, A; Jha, B; Kumar, D | 1 |
Chang, L; Feng, LS; Gao, C; Lv, ZS; Ren, QC; Xu, Z; Zhang, S | 1 |
Carvalho, I; Chierrito, TPC; de Andrade, P; Figueredo, AS; Mantoani, SP | 1 |
Kantevari, S; Sridevi, JP; Sriram, D; Yempala, T; Yogeeswari, P | 1 |
Budagumpi, S; Keri, RS; Nagaraja, BM; Patil, SA | 1 |
Bhatt, JD; Chudasama, CJ; Patel, KD | 1 |
González, GM; Hernández-Balboa, CL; Martínez-Reséndez, MF; Treviño-Rangel, RJ; Villanueva-Lozano, H | 1 |
Joshi, RA; Joshi, RR; Likhite, AP; Nawale, L; Rode, ND; Sarkar, D; Sonawane, AD | 1 |
Chattopadhyaya, J; Dixit, SS; Kulkarni, GM; Sharma, V; Upadhayaya, RS; Vandavasi, JK; Vasireddy, NR | 1 |
Chan, RJ; Franzblau, SG; He, Y; Liu, Y; Luo, Y; Wang, Y; Xu, J; Yang, Z; Zhang, X; Zhang, ZY; Zheng, J; Zhou, B | 1 |
Bhattarai, D; Cho, SN; Kang, SB; Keum, G; Kim, EE; Lee, SH; Nam, G; Oh, T; Pae, AN; Seo, SH | 1 |
Kulkarni, MV; Naik, RJ; Nayak, PG; Sreedhara Ranganath Pai, K | 1 |
NEDELJKOVIC, J | 1 |
Boechat, N; Castro, HC; Costa, MS; da Silva, Fde C; de Souza, AM; Ferreira, VF; Junior, IN; Lourenço, MC; Rangel, EA; Rodrigues, CR; Wardell, SM | 1 |
Chevallet, P; Kaplancikli, ZA; Ozdemir, A; Turan-Zitouni, G | 1 |
Foks, H; Janowiec, M; Rudnicka, W; Zwolska-Kwiek, Z | 1 |
6 review(s) available for triazoles and Koch's Disease
Article | Year |
---|---|
The Medicinal Chemistry of 3-nitro-1,2,4-triazoles: Focus on Infectious Diseases.
Topics: Animals; Chagas Disease; Chemistry, Pharmaceutical; Communicable Diseases; Humans; Leishmaniasis; Mycoses; Triazoles; Trypanosomiasis, African; Tuberculosis | 2021 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Triazole-containing hybrids with anti-
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles; Tuberculosis | 2021 |
Triazole derivatives and their anti-tubercular activity.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2017 |
Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
Topics: Animals; Antiprotozoal Agents; Chagas Disease; Humans; Leishmaniasis; Malaria; Triazoles; Tuberculosis | 2019 |
Triazole: A Promising Antitubercular Agent.
Topics: Animals; Antitubercular Agents; Humans; Triazoles; Tuberculosis | 2015 |
1 trial(s) available for triazoles and Koch's Disease
Article | Year |
---|---|
Twice-Daily Doravirine Overcomes the Interaction Effect from Once-Weekly Rifapentine and Isoniazid in Healthy Volunteers.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyridones; Reverse Transcriptase Inhibitors; Rifampin; Triazoles; Tuberculosis; Young Adult | 2020 |
16 other study(ies) available for triazoles and Koch's Disease
Article | Year |
---|---|
Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
Topics: Antitubercular Agents; HEK293 Cells; Humans; Isatin; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Phosphotransferases (Alcohol Group Acceptor); Shikimic Acid; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking.
Topics: Acyl Carrier Protein; Antitubercular Agents; Bacterial Proteins; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Stabilization of Hypoxia-Inducible Factor Promotes Antimicrobial Activity of Human Macrophages Against
Topics: Basic Helix-Loop-Helix Transcription Factors; Cytokines; Host-Pathogen Interactions; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Models, Biological; Mycobacterium tuberculosis; Protein Stability; Pyrazoles; Receptors, Calcitriol; Triazoles; Tuberculosis | 2021 |
Characterization of a triazole scaffold compound as an inhibitor of Mycobacterium tuberculosis imidazoleglycerol-phosphate dehydratase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Humans; Hydro-Lyases; Mycobacterium tuberculosis; Triazoles; Tuberculosis | 2022 |
Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Benzofurans; Click Chemistry; HEK293 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2014 |
Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Chlorocebus aethiops; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyrimidines; Triazoles; Tuberculosis; Vero Cells | 2015 |
An unusual case of Candida ciferrii fungemia in an immunocompromised patient with Crohn's and Mycobacterium bovis disease.
Topics: Adult; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Catheterization, Central Venous; Crohn Disease; Female; Humans; Immunocompromised Host; Mycobacterium bovis; Treatment Outcome; Triazoles; Tuberculosis | 2016 |
Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Topics: Antitubercular Agents; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Thiones; Triazoles; Tuberculosis | 2017 |
Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; ATP Synthetase Complexes; Bacterial Proteins; Cell Survival; Macrophages; Models, Molecular; Molecular Structure; Murinae; Mycobacterium tuberculosis; Protein Binding; Quinolines; Structure-Activity Relationship; Thiourea; Triazoles; Tuberculosis; Urea | 2009 |
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents.
Topics: Animals; Antitubercular Agents; Apoptosis; Bacterial Proteins; Benzofurans; Cell Line; Cell Survival; Enzyme Inhibitors; Host-Pathogen Interactions; Humans; Interferon-gamma; Kinetics; Macrophages; Mice; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinases; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Protein Tyrosine Phosphatases; Triazoles; Tuberculosis | 2010 |
Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cytochrome P-450 Enzyme System; Drug Design; Ether-A-Go-Go Potassium Channels; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Oxazolidinones; Structure-Activity Relationship; Triazoles; Tuberculosis | 2012 |
Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacteria; Cell Line; Chromones; Click Chemistry; Fungi; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2012 |
[Treatment of tuberculosis with tilted position].
Topics: Triazoles; Tuberculosis; Tuberculosis, Pulmonary | 1951 |
Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Topics: Antitubercular Agents; Crystallography, X-Ray; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2006 |
Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Chemical; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Sulfhydryl Compounds; Triazoles; Tuberculosis | 2007 |
[Studies of pyrazine derivatives. XXI. Synthesis and tuberculostatic activity of 4-aryl-1-pyrazinoylthiosemicarbazides and the products of their cyclization to 1,2,4-triazole-3-thione derivatives].
Topics: Animals; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Mice; Pyrazines; Semicarbazides; Thiones; Triazoles; Tuberculosis | 1986 |